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a,b,c TurkeyObjectives: Red cell distribution width (RDW) and neutrophil-to-lymphocyte ratio (NLR) are the two markers used
to determine risk of mortality and adverse cardiovascular outcomes in patients with acute myocardial infarction. The
relationship between RDW, NLR, and left ventricular (LV) systolic functions has not been reported. In this report, we
aimed to investigate the relationship between RDW, NLR, and LV systolic function in anterior ST-segment elevation
myocardial infarction (STEMI) patients who underwent primary percutaneous coronary intervention (PCI).
Methods: RDW and NLR were measured on admission in 106 STEMI patients treated with primary PCI. Patients
were divided into two groups according to left ventricular ejection fraction (LVEF), as Group I (systolic dysfunction,
LVEF <50%) and Group II (preserved global left ventricle systolic function, LVEF P50%). The first group included
47 patients and the second group included 59 patients.
Results: Mean RDW and NLR were significantly higher in Group I compared to Group II [13.7 ± 0.9% vs.
13.4 ± 0.7%, p = 0.03 and 5.86 (range, 0.66–40.50) vs. 2.75 (range, 0.51–39.39), p = 0.013, respectively].
Conclusion: Increased RDW and NLR on admission, in anterior STEMI patients treated with primary PCI are
associated with LV systolic dysfunction.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Abbreviations
RDW Red cell distribution width
NLR Neutrophil-to-lymphocyte ratio
LV Left ventricular
AMI Acute myocardial infarction
WBC White blood cell
STEMI ST-segment elevation myocardial infarction
LVEF Left ventricular ejection fraction
PCI Primary percutaneous coronary intervention
LAD Left anterior descending coronary artery
TIMI Thrombolysis in myocardial infarction
DM Diabetes mellitus
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LEFT VENTRICULAR DYSFUNCTIONIntroduction
Atherosclerosis is a multifactorial disease andthe major cause of cardiovascular disease
that still accounts for most of the mortality world-
wide [1]. The role of inflammation in the develop-
ment and progression of atherosclerosis has been
clarified and several biological markers of inflam-
mation predict cardiovascular risk [2,3]. Since it is
an inflammatory disease, some inflammatory
markers have been proposed for the evaluation
of the cardiovascular risk. Red cell distribution
width (RDW) and neutrophil-to-lymphocyte ratio
(NLR) are the two markers of inflammation that
are used to determine risk of mortality and
adverse cardiovascular outcomes in patients with
acute myocardial infarction (AMI) [4,5].
RDW is a laboratory measure of the variability
in erythrocyte volume and is easily measured dur-
ing routine complete blood counts [6]. RDW is
generally used as an indicator of the differential
diagnosis of anemia [5]. However, recent studies
have reported that higher RDW is found to be a
strong independent predictor of increased risk of
mortality and adverse cardiovascular events in
patients with heart failure, stable coronary artery
disease, acute coronary syndrome, AMI, cardio-
vascular disease, and also in the general popula-
tion [5,7–11].
White blood cell (WBC) count and its subtypes
are also known as classic markers of inflammation
in cardiovascular diseases [12]. NLR was intro-
duced as a potential marker to determine inflam-
mation in cardiac and noncardiac disorders, and
shown as a predictor of long-term mortality in
patients who underwent percutaneous coronary
intervention in patients with ST-segment eleva-
tion myocardial infarction (STEMI) [13,14]. As
neutrophil and lymphocyte values are readily
available in routine blood count analysis, NLR
may be used as a cost-effective predictor of
inflammation and cardiovascular complications
[4].
Left ventricular ejection fraction (LVEF) is a
parameter used for assessment of left ventricular
systolic function in daily practice and has been
shown to be an efficacious predictor of prognosis
after AMI [15]. The relationship between RDW
and NLR obtained from complete blood count
during first admission to hospital and left ventric-
ular systolic functions is unknown. The goal of this
study was to evaluate the relationship between
RDW and NLR level on admission and left ven-
tricular systolic functions in first anterior STEMIpatients who underwent primary percutaneous
coronary intervention (PCI).Materials and methods
Patients
Medical records of consecutive patients with
acute anterior STEMI who were admitted to the
emergency department of our hospital between
February 2008 and August 2013 were examined
retrospectively. Patients <6 hours from symptom
onset and who underwent primary PCI for the
proximal or the mid-left anterior descending coro-
nary artery lesions and have postinterventional
thrombolysis in myocardial infarction (TIMI) III
flow after primary PCI were enrolled in the study.
Patients were excluded from the study if they had
the following criteria: (1) a history of any heart
disease including myocardial infarction, revascu-
larization, angina pectoris, heart failure, valvular
heart disease, congenital heart disease, and atrial
fibrillation; (2) cardiogenic shock before the
procedure, resuscitated arrest and arrest under
mechanical ventilation, hemodynamically impor-
tant atrioventricular block (2nd or 3rd-degree atri-
oventricular block), thrombolytic administration
before primary PCI; or (3) clinical evidence of
active infection, cancer, hematological disease,
systemic inflammatory conditions, autoimmune
disease, end-stage liver disease and renal failure,
anemia (hemoglobin levels <13 g/dL in men and
12 g/dL in women), pregnancy, or recent blood
transfusion.
Study protocol
A 12-lead electrocardiogram was recorded in
each patient immediately after hospital admis-
sion. On admission, venous blood was obtained
from all the patients. RDW, neutrophils, lympho-
cytes, and white blood cells were measured as part
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starting any medication. The NLR was calculated
as the ratio of the neutrophils and lymphocytes,
both obtained from the same automated blood
sample at admission. All measurements were
performed 30 minutes after blood collection by
an automatic blood counter. The lipid profile was
measured following the first fasting period. A clin-
ical history of age, sex, diabetes mellitus (DM),
hypertension, hyperlipidemia, and smoking was
determined from medical records.
All patients received 300 mg clopidogrel loading
dose and 300 mg aspirin before the primary PCI.
The patients’ angiographic data were evaluated from
catheter laboratory records. Emergency coronary
angiography was performed using the percuta-
neous femoral approach. Unfractioned heparin
(60–100 U/kg) was administered when coronary
anatomy was first defined. Primary PCI was per-
formed to infarct related artery. After angioplasty,
all patients were admitted to the coronary care
unit, where intravenous heparin or subcutaneous
low-molecular weight heparin was administered;
100 mg aspirin and 75 mg clopidogrel were contin-
ued in all patients. Use of glycoprotein IIb/IIIa
inhibitors was left to operators’ preference. TIMI
flows were estimated according to Gibson et al.’s
[16] method. Patients without TIMI III flow after
angioplasty were excluded from the study.
Echocardiographic data were obtained from
patients’ record. A two-dimensional transthoracic
echocardiography was performed in the left lat-
eral decubitus position with the Vivid 7 system
(GE-Vingmed Ultrasound AS, Horten, Norway)
ultrasound device and a 3S-RS (3.5 MHz) probe.
Echocardiographic examinations were performed
according to the guidelines of American Society
of Echocardiography [17]. Patients were divided
into two groups according to their LVEF. The first
group included patients with a depressed left
ventricle systolic function (LVEF <50%), and the
second group included patients with a preserved
left ventricle systolic function (LVEF P50%).Figure 1. Patient flow.Definitions
Anterior STEMI was defined when a patient had
typical chest pain for at least 30 minutes with
>2 mm ST elevation in at least two consecutive
anterior derivations. Hypertension was consid-
ered to be present if the systolic pressure was
>140 mmHg and/or diastolic pressure was
>90 mmHg for at least two separate measure-
ments, or the previous use of antihypertensive
drugs. DM was defined as a fasting blood glucose
level >126 mg/dL or current use of a diet ormedication to lower blood glucose. Anemia was
defined as hemoglobin levels <13 g/dL in men
and 12 g/dL in women, in accordance with the
World Health Organization criteria [18].
Statistical analysis
Pearson Chi-square and Fisher’s exact tests
were used to compare the incidence of categorical
variables among groups. Categorical variables
were presented as counts and percentages. The
Kolmogorov–Smirnov and Shapiro–Wilks tests
were used to evaluate whether the distribution
of variables was normal. The two independent
sample t test or Mann–Whitney U test was used
to compare continuous variables between the
two groups. Continuous variables were presented
as mean (standard deviation) or as median
(range). SPSS software 18.0 for Windows (SPSS
Inc., Chicago, IL, USA) was used for all statistical
analysis. A multivariable logistic regression model
was used to evaluate the independent contribu-
tion of NLR and RDW to the risk of LV systolic
dysfunction. Age, NLR, RDW, and fasting glucose
levels were selected for multivariable logistic
regression analyses. The RDW and NLR values
were implemented as continuous variables for
analyses. The adjusted odd ratios and 95%
confidence intervals are presented. Calculated
p-values were considered statistically significant
when they were <0.05.Results
Baseline characteristics
Of 248 patients enrolled with first anterior
STEMI, 142 were excluded due to exclusion crite-
ria (Fig. 1). Group I (LVEF <50%) included 47
patients, and Group II (LVEF P50%) included 59
Table 1. Baseline characteristics in the study groups.
Group I
(n = 47)
Group II
(n = 59)
p
Age (y) 55 ± 13 55 ± 11 0.728
Male 36 (77) 48 (81) 0.548
BMI (kg/m2) 27 ± 4 27 ± 3 0.314
Creatinine (mg/dL) 0.89 (0.5–1.7) 0.90 (0.5–1.7) 0.187
Troponine (ng/L) 0.13 (0.003–19.20) 0.046 (0.001–6.67) 0.061
LDL cholesterol (mg/dL) 110 ± 32 118 ± 32 0.184
HT 22 (47) 29 (49) 0.810
DM 17 (36) 14 (24) 0.162
Current smoker 22 (47) 28 (48) 0.947
Tirofiban 8 (17) 17 (29) 0.155
Culprit lesion 0.143
Proximal 35 (74.5) 36 (61.0)
Medial 12 (25.5) 23 (39.0)
TIMI flow 0.712
TIMI 0 34 (72.3) 38 (64.4)
TIMI 1 8 (17.0) 12 (20.3)
TIMI 2 5 (10.7) 8 (13.6)
TIMI 3 0 1 (1.7)
Data are presented as n (%), mean ± SD, or median (range).
BMI = body mass index; DM = diabetes mellitus; HT = hypertension; LDL = low-density lipoprotein; SD = standard deviation; TIMI = thrombolysis in
myocardial infarction.
Table 3. Multivariate logistic regression analyses.
Variables Odds ratio CI 95% p
RDW 1.797 1.062–3.041 0.029
NLR 1.078 0.996–1.167 0.063
Glucose 1.005 1.000–1.010 0.069
Age 0.995 0.960–1.030 0.762
CI = confidence interval; NLR = neutrophil lymphocyte ratio;
RDW = red cell distribution width.
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LEFT VENTRICULAR DYSFUNCTIONpatients. On comparison of the two groups, there
were no differences in age, sex, body mass index,
hypertension, DM, smoking status, TIMI flow,
localization of the culprit lesion, or use of glyco-
protein IIb/IIIa inhibitors. Baseline characteristics
are shown in Table 1.
Laboratory findings
Therewas no statistically significant difference in
blood glucose levels, creatinine, troponin, hemo-
globin, hematocrit, leukocyte, mean corpuscular
volume, platelet, or low-density lipoprotein level.
There was a significant difference in neutrophil
and lymphocyte counts [9.39  109/L (3.1–19.52 
109/L) vs. 7.3  109/L (3.61–19.70  109/L), p = 0.037
and 1700 (400–6930) vs. 2600 (396–8100), p = 0.021,
respectively], RDW and NLR levels [13.7 ± 0.9%
vs. 13.4 ± 0.7%, p = 0.03 and 5.86 (0.66–40.50) vs.Table 2. Hemogram test results in the study groups.
Group I
(n = 47)
Hb (g/dL) 14.7 ± 1.6
MCV (fL) 88 (64–104)
WBC (109/L) 12.40 (5.31–21.030
PLT (109/L) 260 (162–666)
RDW (%) 13.7 ± 0.9
Neutrophil (109/L) 9.39 (3.10–19.52)
Lymphocyte (109/L) 1.70 (0.40–6.93)
NLR 5.86 (0.66–40.50)
Data are presented as mean ± SD or median (range).
Hb = hemoglobin; MCV = mean corpuscular volume; NLR = neutrophil
SD = standard deviation; WBC = white blood cells.2.75 (0.51–39.39), p = 0.013, respectively]. Labora-
tory test results are shown in Table 2. For LV
systolic dysfunction; age, NLR, RDW, and fasting
glucose level at admission were analyzed using a
multivariate logistic regression model. The RDW
was the only independent predictor of LV systolic
dysfunction (odds ratio 1.797, 95% confidence
interval 1.062–3.041, p = 0.029; Table 3).Group II
(n = 59)
p
14.8 ± 1.3 0.857
88 (61–95) 0.416
11.77 (5.51–22.70) 0.335
282 (154–510) 0.131
13.4 ± 0.7 0.030
7.30 (3.61–19.70) 0.037
2.60 (0.40–8.10) 0.021
2.75 (0.51–39.39) 0.013
lymphocyte ratio; PLT = platelets; RDW = red distribution width;
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RDW and NLR have recently emerged as a
potential new biomarkers that single out individu-
als at risk for future cardiovascular events in
STEMI patients. In our study, we investigated
the relationship between RDW, NLR and left ven-
tricular systolic functions in first anterior STEMI
patients. In our study population patients with
depressed left ventricle function had significantly
higher RDW and NLR levels than patients with
preserved left ventricular function.
RDW reflects the variability in circulating red
blood cell size and is increased in conditions such
as iron, vitamin B12, and folate deficiency, hemo-
globinopathies, and blood transfusion [9]. Also,
recent studies showed that RDW was associated
with an increased risk of coronary heart disease
events, possibly because it reflects the bone mar-
row’s response to systemic ongoing inflammation
[19]. Inflammation may influence erythropoiesis,
erythrocyte circulatory half-life, and erythrocyte
deformability, promoting anisocytosis and thus
increasing RDW level [20]. Increased RDW was
found to be an independent predictor of mortality
in patients with heart failure, in patients with
prior myocardial infarctions without symptomatic
heart failure, and in patients presenting with
acute myocardial infarction [5,7]. The underlying
mechanism explaining RDW’s association with
cardiovascular events is not clear. Possible mech-
anisms may include oxidative stress, inflamma-
tory, and neurohormonal activation [21,22].
Oxidative stress has been shown to be associated
with RDW. Antioxidants, including serum sele-
nium, total carotenoids were shown to be signifi-
cantly associated with a decrease in RDW. IL-6
was found to be an attenuating factor for this asso-
ciation [23]. It has been shown that the most
important factor in mortality and morbidity after
AMI was left ventricular systolic functions.
Inflammation, oxidative stress, and neurohor-
monal activation play major roles in the pathogen-
esis of atherosclerosis, STEMI, and left ventricular
remodeling after AMI [4,24]. An elevated RDW
may reflect underlying inflammation and oxida-
tive stress in STEMI and left ventricular remodel-
ing after AMI and may be proposed as a simple
diagnostic marker for monitoring patients with
STEMI. Furthermore, neurohumoral activation
may influence erythropoiesis. The sympathetic
and renin–angiotensin systems may accelerate
erythropoiesis by stimulating the release of ery-
thropoietin [25]. Erythropoietin is the hormone
responsible for regulation of the production ofred cells by bone marrow and increased plasma
levels of erythropoietin have been found in
STEMI patients independent of hemoglobin levels
[26].
In previous studies, it has been shown that
white blood cell count and its subtypes were indi-
cators of systemic inflammation and had a consid-
erable role in modulating the inflammatory
response in the atherosclerotic process [12,27]. In
the acute period, leukocytosis usually accompa-
nies STEMI in proportion to the magnitude of
the necrotic process, elevated glucocorticoid
levels, and possibly inflammation in the coronary
arteries [4,14]. Neutrophils are the first leukocytes
to be found in the damaged myocardial area.
Activation of neutrophils produces a large amount
of inflammatory mediators that have important
microcirculatory effects and regulates the inflam-
matory response to tissue injury [14]. Additionally,
in previous studies, increased neutrophil count
has been independently and strongly associated
to large infarct size, mechanical complication,
and mortality in patients with acute myocardial
infarction [28,29]. In the acute setting of coronary
events, lymphocytopenia is a common finding
during the stress response secondary to increased
corticosteroids levels [30]. Furthermore, in AMI
patients, lymphopenia and decreased CD4 counts
with inverted CD4/CD8 ratio are related with low
ejection fraction, high degree of myocardial
necrosis, and mortality [31].
The NLR is a combination of two independent
markers of inflammation; neutrophils show the
ongoing nonspecific inflammation and lympho-
cytes show the regulatory pathway [4]. Unlike
many other inflammatory markers and bioassays,
NLR is an inexpensive and readily available mar-
ker that provides an additional level of risk scores
in predicting in-hospital and long-term outcomes
[4,14].
In the literature, there are several studies which
focused on RDW and NLR and their association
with adverse outcomes in patients with AMI. Isık
et al. [32] showed that RDW level was associated
with mid-termmortality of STEMI patients treated
with primary PCI. Moreover, Uyarel et al. [11]
demonstrated that a high admission RDW level
in patients with STEMI undergoing primary PCI
was associated with an increased risk for in hospi-
tal and long term cardiovascular events such as
advanced heart failure, the time of hospital stay
and mortality. Similarly Dabbah et al. [33] con-
cluded that RDW was independently associated
with mortality after STEMI. In another study,
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LEFT VENTRICULAR DYSFUNCTIONBaysal et al. [34] examined 102 STEMI patients
treated primarily with thrombolytic therapy; they
found that RDW and NLR were significantly
higher in the failed thrombolysis group than in
the successful thrombolysis group and an
increased RDW was found to be strongly and
independently associated with failed thrombolysis
in the setting of acute STEMI. Akpek et al. [35]
showed that preprocedural NLR is an indepen-
dent predictor of no-reflow in STEMI patients.
They speculated that neutrophilia may aggravate
myocardial ischemia by neutrophil-mediated
microvascular plugging and may extend the
infarct area [35]. Nuñez et al. [36] evaluated the
predictive value of NLR in long-term mortality in
STEMI patients and found that an increased
NLR is associated with an increased risk of long-
term mortality. Moreover Shen et al. [14] con-
cluded that NLR is independently and closely
related with long-term mortality in STEMI. In
both of these single-center studies; NLR was mea-
sured at admission and following days up to 3–
4 days. We measured NLR at admission before
starting any medication because leukocyte count
and its subtypes (neutrophils and lymphocytes)
could be affected by infectious disorders, anxiety,
and medication.
Similar to previous studies, our current study
has confirmed the relationship between NLR,
RDW, and STEMI. However, there is no study
evaluating the association between NLR, RDW
levels, and left ventricular systolic functions after
anterior STEMI patients who underwent primary
PCI. In the present study, we investigated
whether the relationship between LVEF, NLR,
and RDW and we found that patients with
depressed left ventricular systolic function (LVEF
<50%) had higher admission NLR and RDW levels
than patients with preserved left ventricular sys-
tolic function (LVEF P50%). We showed that
RDW was an independent predictor of depressed
left ventricular systolic function in anterior STEMI
patients. However, the NLR did not reach a statis-
tically significant level in multivariate analyses.
The lack of a statistically significant level in the
NLR values was thought to have resulted from
the low number of study patients. Also, it was
considered that an increased number of patients
would produce a statistically significant level in
the NLR values. Therefore, we propose that the
increased NLR and RDW level may have caused
an inflammatory response in the coronary arteries
and worsen microvascular perfusion, and thereby
affected left ventricular functions.Study limitations
The limitations of the present study are as
follows. (1) This was a retrospective and single-
center study that included a relatively small
number of patients. Further studies with a larger
sample size may be needed. (2) Only one
measurement of admission full blood count and
calculation of RDW was included in the analysis.
(3) We could not compare RDW with other
inflammatory markers, such as C-reactive protein,
fibrinogen, or myeloperoxidase, because they
were not routinely measured in our study popula-
tion. (4) Elevated RDW levels are affected by many
clinical settings such as iron deficiency, preg-
nancy, vitamin B12 and folate deficiency, and
blood transfusions. Only hemoglobin levels were
measured in our study and other factors includ-
ing, iron, vitamin B12, and folate levels were not
measured in our study. Also, we did not include
patients with anemia in our study. We believe that
this makes it highly unlikely that the RDW values
were not related to iron deficiency. Furthermore,
the incidence of clinically significant vitamin B12
and folate deficiency is low in a modern popula-
tion. In another study it was found that RDW
was an independent predictor of mortality and
the investigators concluded that the relationship
between RDW and mortality was not confounded
by anemia-related deficiencies such as iron, folate,
and vitamin B12 [37].Conclusion
Our findings, although they do not prove a
direct relationship, suggest that higher NLR and
RDW levels, in patients admitting to the emer-
gency department with acute anterior STEMI,
are associated with left ventricular systolic dys-
function and thus, may show potential for use as
a prognostic marker. We think that these signifi-
cant findings can guide further clinical practice.
However, these findings must be confirmed on a
study with more patients.
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